BioSpace News Archive

Press Releases

Results Presented at 2026 American Academy of Dermatology (AAD) Annual Meeting Provide Additional Support for the Therapeutic Potential of ATI-2138

March 30, 2026
·
6 min read
Press Releases

Ascelia Pharma Announces Acceptance of Orviglance Data for Oral Presentation at the Annual Radiology Congress ESGAR 2026

March 30, 2026
·
2 min read
Press Releases

Artelo Biosciences Announces $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

March 30, 2026
·
4 min read
Press Releases

Celldex Presents Positive Data from Phase 2 Chronic Spontaneous Urticaria and Phase 2 Cold Urticaria and Symptomatic Dermographism Studies Demonstrating Rapid, Profound and Durable Improvements in Patient Quality of Life at AAD 2026

March 30, 2026
·
10 min read
Press Releases

LB Pharmaceuticals Presents New Analysis from the Phase 2 NOVA-1 Trial Highlighting LB-102’s Potential Impact on Cognitive Performance at the 2026 Annual Congress of the Schizophrenia International Research Society (SIRS)

March 30, 2026
·
8 min read
Press Releases

Sun Pharma Highlights Advances in Alopecia Areata, Psoriasis, and Acne Research at 2026 AAD Annual Meeting

March 30, 2026
·
14 min read
Press Releases

Lebrikizumab delivered long-term disease control for up to four years in patients with moderate-to-severe atopic dermatitis

March 30, 2026
·
9 min read
Press Releases

Monopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update

March 30, 2026
·
8 min read
Press Releases

Egetis Announces FDA Acceptance and Priority Review of NDA for Emcitate(R) (tiratricol) for MCT8 Deficiency

March 30, 2026
·
4 min read
Press Releases

Entera Bio Announces Full Year 2025 Financial Results and Provides Business Updates

March 30, 2026
·
13 min read